Showing 3 of 3 recruiting trials for “dicer1-tumor-predisposition-syndrome”
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
RecruitingNCT04431024 ↗
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
RecruitingNCT01247597 ↗
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
👨⚕️ Douglas R Stewart, M.D., National Cancer Institute (NCI)📍 2 sites📅 Started Feb 2011View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →